MARKETSDow Trades Lower on Rates Fears, Tech Shares Sink NasdaqBy TheStreet StaffOct 18, 2018 4:05 PM EDT
INVESTINGNovartis Snaps up Prostate Cancer Treatment with Endocyte DealBy Paul WhitfieldOct 18, 2018 9:16 AM EDT
MARKETSFacebook, Fed Minutes, AmEx, PayPal and Endocyte - 5 Things You Must KnowBy Joseph WoelfelOct 18, 2018 7:17 AM EDT
OPINIONSmall-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 YearsBy Brian SozziMar 14, 2018 6:23 PM EDT
MARKETSEndocyte (ECYT) Showing Signs Of A Dead Cat Bounce TodayBy David M. AferiatSep 19, 2014 9:55 AM EDT
MARKETSEndocyte (ECYT) Showing Signs Of A Dead Cat Bounce TodayBy David M. AferiatSep 12, 2014 10:08 AM EDT
MARKETSEndocyte (ECYT) Showing Signs Of Perilous Reversal TodayBy Scott OlsonSep 11, 2014 9:46 AM EDT
STOCKSBiotech Stock Mailbag: Achillion, Ariad Revisited, EndocyteBy Adam FeuersteinSep 5, 2014 8:55 AM EDT
INVESTINGA Beaten-Down Biotech Stock Poised for an Epic Short SqueezeBy Roberto PedoneJun 17, 2014 5:50 PM EDT
MARKETSWhy Endocyte (ECYT) Stock Is Plummeting in After-Hours Trading TodayBy Andrew MeolaJun 17, 2014 4:36 PM EDT
MARKETSHow Will This Coverage Initiation Affect Endocyte (ECYT) Stock Today?By Tony OwusuJun 5, 2014 9:48 AM EDT
MARKETSWhy Endocyte (ECYT) Stock Plummeted to a One-Year Low TodayBy Andrew MeolaMay 2, 2014 11:12 AM EDT
